Alpha Cognition Inc. Selling, General and Administrative Expense
Alpha Cognition Inc. (ACOG) reported Selling, General and Administrative Expense of $11.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-13
- Alpha Cognition Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $11.45M, a 20.58% increase year-over-year.
- Alpha Cognition Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $10.26M, a 101.45% increase year-over-year.
- Alpha Cognition Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $9.89M, a 506.15% increase year-over-year.
- Alpha Cognition Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $6.95M, a 371.86% increase year-over-year.
- Alpha Cognition Inc. selling, general and administrative expense for fiscal 2025 was $29.08M, a 262.90% increase from fiscal 2024.
- Alpha Cognition Inc. selling, general and administrative expense for fiscal 2024 was $8.01M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11.45M 10-Q · filed 2026-08-13 | $21.71M 10-Q · filed 2026-08-13 | $31.60M derived: sum of 3 quarters · filed 2026-08-13 | $38.54M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $10.26M 10-Q · filed 2026-05-14 | $20.15M derived: sum of 2 quarters · filed 2026-05-14 | $27.09M derived: sum of 3 quarters · filed 2026-05-14 | $36.59M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $9.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $16.84M derived: sum of 2 quarters · filed 2026-03-31 | $26.33M derived: sum of 3 quarters · filed 2026-08-13 | $29.08M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $6.95M 10-Q · filed 2025-11-13 | $16.44M derived: sum of 2 quarters · filed 2026-08-13 | $19.19M 10-Q · filed 2025-11-13 | $23.16M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $9.49M 10-Q · filed 2026-08-13 | $6.54M 10-Q · filed 2025-08-14 | $14.59M 10-Q · filed 2026-08-13 | $11.90M 10-Q · filed 2025-08-14 | $16.22M derived: sum of 3 quarters · filed 2026-08-13 | $17.69M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $5.09M 10-Q · filed 2026-05-14 | $5.37M 10-Q · filed 2025-05-15 | $6.72M derived: sum of 2 quarters · filed 2026-05-14 | $8.20M derived: sum of 3 quarters · filed 2026-05-14 | $9.63M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.10M derived: sum of 2 quarters · filed 2026-03-31 | $4.54M derived: sum of 3 quarters · filed 2026-03-31 | $8.01M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $1.47M 10-Q · filed 2025-11-13 | $2.91M derived: sum of 2 quarters · filed 2025-11-13 | $6.38M 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $1.43M 10-Q · filed 2025-08-14 | $4.91M 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | $3.47M 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |